Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 398

1.

Primary dural lymphomas: Clinical presentation, management, and outcome.

Karschnia P, Batchelor TT, Jordan JT, Shaw B, Winter SF, Barbiero FJ, Kaulen LD, Thon N, Tonn JC, Huttner AJ, Fulbright RK, Loeffler J, Dietrich J, Baehring JM.

Cancer. 2020 Mar 16. doi: 10.1002/cncr.32834. [Epub ahead of print]

PMID:
32176324
2.

Resting-state fMRI Detects Alterations in Whole Brain Connectivity Related to Tumor Biology in Glioma Patients.

Stoecklein VM, Stoecklein S, Galiè F, Ren J, Schmutzer M, Unterrainer M, Albert NL, Kreth FW, Thon N, Liebig T, Ertl-Wagner B, Tonn JC, Liu H.

Neuro Oncol. 2020 Feb 28. pii: noaa044. doi: 10.1093/neuonc/noaa044. [Epub ahead of print]

PMID:
32107555
3.

Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis.

Mirian C, Duun-Henriksen AK, Juratli T, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L, Maier AD, Møller Pedersen M, Law I, Broholm H, Cahill DP, Brastianos P, Poulsgaard L, Fugleholm K, Ziebell M, Munch T, Mathiesen T.

J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):378-387. doi: 10.1136/jnnp-2019-322257. Epub 2020 Feb 10. Review.

PMID:
32041819
4.

Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.

Cai L, Kirchleitner SV, Zhao D, Li M, Tonn JC, Glass R, Kälin RE.

Int J Mol Sci. 2020 Jan 17;21(2). pii: E612. doi: 10.3390/ijms21020612.

5.

Clinical Results After Single-fraction Radiosurgery for 1,002 Vestibular Schwannomas.

Windisch PY, Tonn JC, Fürweger C, Wowra B, Kufeld M, Schichor C, Muacevic A.

Cureus. 2019 Dec 16;11(12):e6390. doi: 10.7759/cureus.6390.

6.

Effect of early palliative care for patients with glioblastoma (EPCOG): a randomised phase III clinical trial protocol.

Golla H, Nettekoven C, Bausewein C, Tonn JC, Thon N, Feddersen B, Schnell O, Böhlke C, Becker G, Rolke R, Clusmann H, Herrlinger U, Radbruch L, Vatter H, Güresir E, Stock S, Müller D, Civello D, Papachristou I, Hellmich M, Hamacher S, Voltz R, Goldbrunner R; EPCOG study group.

BMJ Open. 2020 Jan 7;10(1):e034378. doi: 10.1136/bmjopen-2019-034378.

7.

Surgery of degenerative thoracic spinal stenosis-long-term outcome with quality-of-life after posterior decompression via an uni- or bilateral approach.

Siller S, Pannenbaecker L, Tonn JC, Zausinger S.

Acta Neurochir (Wien). 2020 Feb;162(2):317-325. doi: 10.1007/s00701-019-04191-x. Epub 2019 Dec 23.

PMID:
31873792
8.

Spinal intradural extramedullary arachnoid cysts in adults-operative therapy and clinical outcome.

Schmutzer M, Tonn JC, Zausinger S.

Acta Neurochir (Wien). 2020 Mar;162(3):691-702. doi: 10.1007/s00701-019-04156-0. Epub 2019 Dec 7.

PMID:
31813001
9.

Prognostic value of a bilateral motor threshold criterion for facial corticobulbar MEP monitoring during cerebellopontine angle tumor resection.

Greve T, Wang L, Thon N, Schichor C, Tonn JC, Szelényi A.

J Clin Monit Comput. 2019 Nov 29. doi: 10.1007/s10877-019-00434-5. [Epub ahead of print]

PMID:
31784853
10.

Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome.

Biczok A, Jungk C, Egensperger R, von Deimling A, Suchorska B, Tonn JC, Herold-Mende C, Schichor C.

J Neurooncol. 2019 Dec;145(3):469-477. doi: 10.1007/s11060-019-03312-x. Epub 2019 Nov 11.

PMID:
31713016
11.

Significance of cerebrospinal fluid inflammatory markers for diagnosing external ventricular drain-associated ventriculitis in patients with severe traumatic brain injury.

Lenski M, Biczok A, Neufischer K, Tonn JC, Briegel J, Thon N.

Neurosurg Focus. 2019 Nov 1;47(5):E15. doi: 10.3171/2019.8.FOCUS19407.

PMID:
31675710
12.

Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT.

Unterrainer M, Ruf V, Cyran CC, Brendel M, Thon N, Herms J, Schüller U, Tonn JC, Bartenstein P, Albert NL.

Clin Nucl Med. 2019 Nov;44(11):923-924. doi: 10.1097/RLU.0000000000002790.

PMID:
31584491
13.

Comment on "Hypometabolic gliomas on FET-PET-is there an inverted U-curve for survival?"

Galldiks N, Verger A, Zaragori T, Unterrainer M, Suchorska B, Lohmann P, Tonn JC, Langen KJ, Albert NL.

Neuro Oncol. 2019 Dec 17;21(12):1612-1613. doi: 10.1093/neuonc/noz173. No abstract available.

PMID:
31504819
14.

EANO guideline on the diagnosis and treatment of vestibular schwannoma.

Goldbrunner R, Weller M, Regis J, Lund-Johansen M, Stavrinou P, Reuss D, Evans DG, Lefranc F, Sallabanda K, Falini A, Axon P, Sterkers O, Fariselli L, Wick W, Tonn JC.

Neuro Oncol. 2020 Jan 11;22(1):31-45. doi: 10.1093/neuonc/noz153.

PMID:
31504802
15.

TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study.

Unterrainer M, Fleischmann DF, Vettermann F, Ruf V, Kaiser L, Nelwan D, Lindner S, Brendel M, Wenter V, Stöcklein S, Herms J, Milenkovic VM, Rupprecht R, Tonn JC, Belka C, Bartenstein P, Niyazi M, Albert NL.

Eur J Nucl Med Mol Imaging. 2019 Sep 5. doi: 10.1007/s00259-019-04491-5. [Epub ahead of print]

PMID:
31486876
16.

Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression.

Galldiks N, Kocher M, Ceccon G, Werner JM, Brunn A, Deckert M, Pope WB, Soffietti R, Le Rhun E, Weller M, Tonn JC, Fink GR, Langen KJ.

Neuro Oncol. 2020 Jan 11;22(1):17-30. doi: 10.1093/neuonc/noz147.

PMID:
31437274
17.

Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic 18F-FET PET.

Vettermann F, Suchorska B, Unterrainer M, Nelwan D, Forbrig R, Ruf V, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL.

Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2581-2589. doi: 10.1007/s00259-019-04477-3. Epub 2019 Aug 13.

PMID:
31410540
18.

How we treat glioblastoma.

Weller M, Le Rhun E, Preusser M, Tonn JC, Roth P.

ESMO Open. 2019 Jun 17;4(Suppl 2):e000520. doi: 10.1136/esmoopen-2019-000520. eCollection 2019. Review.

19.

Indication and technical implementation of the intraoperative neurophysiological monitoring during spine surgeries-a transnational survey in the German-speaking countries.

Siller S, Raith C, Zausinger S, Tonn JC, Szelenyi A.

Acta Neurochir (Wien). 2019 Sep;161(9):1865-1875. doi: 10.1007/s00701-019-03974-6. Epub 2019 Jun 21.

PMID:
31227966
20.

Long-term outcome in orbital meningiomas: progression-free survival after targeted resection combined with early or postponed postoperative radiotherapy.

Terpolilli NA, Ueberschaer M, Niyazi M, Hintschich C, Egensperger R, Muacevic A, Thon N, Tonn JC, Schichor C.

J Neurosurg. 2019 Jun 14:1-11. doi: 10.3171/2019.3.JNS181760. [Epub ahead of print]

PMID:
31200373
21.

Teaching NeuroImages: Advanced imaging of neurosarcoidosis with 68Ga-DOTATATE PET/CT.

Unterrainer M, Ruf V, Ilhan H, Vettermann F, Holzgreve A, Cyran CC, Tonn JC, Bartenstein P, Albert NL.

Neurology. 2019 May 21;92(21):e2512-e2513. doi: 10.1212/WNL.0000000000007544. No abstract available.

PMID:
31110154
22.

Domesticated Animals on Exhibit at the Museum of Comparative Zoology, 1900-1928.

Tonn J.

Endeavour. 2019 Mar - Jun;43(1-2):32-36. doi: 10.1016/j.endeavour.2019.04.002. Epub 2019 May 10.

PMID:
31084945
23.

Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients.

Galldiks N, Unterrainer M, Judov N, Stoffels G, Rapp M, Lohmann P, Vettermann F, Dunkl V, Suchorska B, Tonn JC, Kreth FW, Fink GR, Bartenstein P, Langen KJ, Albert NL.

Neuro Oncol. 2019 Oct 9;21(10):1331-1338. doi: 10.1093/neuonc/noz083.

PMID:
31077276
24.

DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.

Binder H, Willscher E, Loeffler-Wirth H, Hopp L, Jones DTW, Pfister SM, Kreuz M, Gramatzki D, Fortenbacher E, Hentschel B, Tatagiba M, Herrlinger U, Vatter H, Matschke J, Westphal M, Krex D, Schackert G, Tonn JC, Schlegel U, Steiger HJ, Wick W, Weber RG, Weller M, Loeffler M.

Acta Neuropathol Commun. 2019 Apr 25;7(1):59. doi: 10.1186/s40478-019-0704-8.

25.

Introduction of intraoperative neuromonitoring does not necessarily improve overall long-term outcome in elective aneurysm clipping.

Greve T, Stoecklein VM, Dorn F, Laskowski S, Thon N, Tonn JC, Schichor C.

J Neurosurg. 2019 Mar 29:1-9. doi: 10.3171/2018.12.JNS182177. [Epub ahead of print]

PMID:
30925469
26.

Diffusion-weighted magnetic resonance imaging for detection of postoperative intracranial pyogenic abscesses in neurosurgery.

Schwartz C, Lenski M, Romagna A, Schichor C, Tonn JC, Brueckmann H, Janssen H, Liebig T, Forbrig R, Thon N.

Acta Neurochir (Wien). 2019 May;161(5):985-993. doi: 10.1007/s00701-019-03875-8. Epub 2019 Mar 26.

PMID:
30915573
27.

Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis.

Körber V, Yang J, Barah P, Wu Y, Stichel D, Gu Z, Fletcher MNC, Jones D, Hentschel B, Lamszus K, Tonn JC, Schackert G, Sabel M, Felsberg J, Zacher A, Kaulich K, Hübschmann D, Herold-Mende C, von Deimling A, Weller M, Radlwimmer B, Schlesner M, Reifenberger G, Höfer T, Lichter P.

Cancer Cell. 2019 Apr 15;35(4):692-704.e12. doi: 10.1016/j.ccell.2019.02.007. Epub 2019 Mar 21.

PMID:
30905762
28.

The surgical perspective in precision treatment of diffuse gliomas.

Thon N, Tonn JC, Kreth FW.

Onco Targets Ther. 2019 Feb 22;12:1497-1508. eCollection 2019. Review.

29.

68Ga-DOTATOC PET/CT Differentiates Meningioma From Dural Metastases.

Unterrainer M, Ruf V, Ilhan H, Vettermann FJ, Cyran CC, Niyazi M, Bartenstein P, Tonn JC, Albert NL.

Clin Nucl Med. 2019 May;44(5):412-413. doi: 10.1097/RLU.0000000000002513.

PMID:
30829858
30.

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.

Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society.

Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14.

PMID:
30782343
31.

Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma.

Mastrella G, Hou M, Li M, Stoecklein VM, Zdouc N, Volmar MNM, Miletic H, Reinhard S, Herold-Mende CC, Kleber S, Eisenhut K, Gargiulo G, Synowitz M, Vescovi AL, Harter PN, Penninger JM, Wagner E, Mittelbronn M, Bjerkvig R, Hambardzumyan D, Schüller U, Tonn JC, Radke J, Glass R, Kälin RE.

Cancer Res. 2019 May 1;79(9):2298-2313. doi: 10.1158/0008-5472.CAN-18-0881. Epub 2019 Feb 4.

PMID:
30718358
32.

Outcome after individualized stereoelectroencephalography (sEEG) implantation and navigated resection in patients with lesional and non-lesional focal epilepsy.

Thorsteinsdottir J, Vollmar C, Tonn JC, Kreth FW, Noachtar S, Peraud A.

J Neurol. 2019 Apr;266(4):910-920. doi: 10.1007/s00415-019-09213-3. Epub 2019 Jan 30.

PMID:
30701313
33.

Use of a New Indocyanine Green Pooling Technique for Improved Visualization of Spinal Dural AV Fistula: A Single-Center Case Series.

Thorsteinsdottir J, Siller S, Dorn F, Briegel J, Tonn JC, Schichor C.

World Neurosurg. 2019 May;125:e67-e73. doi: 10.1016/j.wneu.2018.12.190. Epub 2019 Jan 16.

PMID:
30659976
34.

Imaging and diagnostic advances for intracranial meningiomas.

Huang RY, Bi WL, Griffith B, Kaufmann TJ, la Fougère C, Schmidt NO, Tonn JC, Vogelbaum MA, Wen PY, Aldape K, Nassiri F, Zadeh G, Dunn IF; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i44-i61. doi: 10.1093/neuonc/noy143.

35.

Advances in multidisciplinary therapy for meningiomas.

Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, Wen PY, Aldape K, Nassiri F, Zadeh G, Jenkinson MD, Raleigh DR; International Consortium on Meningiomas .

Neuro Oncol. 2019 Jan 14;21(Supplement_1):i18-i31. doi: 10.1093/neuonc/noy136.

36.

PET imaging in patients with brain metastasis-report of the RANO/PET group.

Galldiks N, Langen KJ, Albert NL, Chamberlain M, Soffietti R, Kim MM, Law I, Le Rhun E, Chang S, Schwarting J, Combs SE, Preusser M, Forsyth P, Pope W, Weller M, Tonn JC.

Neuro Oncol. 2019 May 6;21(5):585-595. doi: 10.1093/neuonc/noz003.

PMID:
30615138
37.

Whole-Body Staging of Metastatic Atypical Meningioma Using 68Ga-DOTATATE PET/CT.

Unterrainer M, Ilhan H, Vettermann F, Cyran CC, Tonn JC, Niyazi M, Bartenstein P, Albert NL.

Clin Nucl Med. 2019 Mar;44(3):227-228. doi: 10.1097/RLU.0000000000002422.

PMID:
30589668
38.

Stereotactic Internal Shunt Placement in Congenital Intracranial Cysts.

Lenski M, Biczok A, Tonn JC, Kreth FW.

World Neurosurg. 2019 Mar;123:e670-e677. doi: 10.1016/j.wneu.2018.11.250. Epub 2018 Dec 18.

PMID:
30576829
39.

Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning.

Suchorska B, Schüller U, Biczok A, Lenski M, Albert NL, Giese A, Kreth FW, Ertl-Wagner B, Tonn JC, Ingrisch M.

Eur J Cancer. 2019 Jan;107:15-27. doi: 10.1016/j.ejca.2018.10.019. Epub 2018 Dec 7.

PMID:
30529899
40.

Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0.

Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, la Fougère C, Langen KJ, Lopci E, Lowe V, McConathy J, Quick HH, Sattler B, Schuster DM, Tonn JC, Weller M.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):540-557. doi: 10.1007/s00259-018-4207-9. Epub 2018 Dec 5.

41.

Laboratory of domesticity: Gender, race, and science at the Bermuda Biological Station for Research, 1903-30.

Tonn J.

Hist Sci. 2019 Jun;57(2):231-259. doi: 10.1177/0073275318797789. Epub 2018 Oct 11.

PMID:
30309265
42.

Role of Cerebrospinal Fluid Markers for Predicting Shunt-Dependent Hydrocephalus in Patients with Subarachnoid Hemorrhage and External Ventricular Drain Placement.

Lenski M, Biczok A, Huge V, Forbrig R, Briegel J, Tonn JC, Thon N.

World Neurosurg. 2019 Jan;121:e535-e542. doi: 10.1016/j.wneu.2018.09.159. Epub 2018 Sep 27.

PMID:
30268545
43.

Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study.

Unterrainer M, Fleischmann DF, Diekmann C, Vomacka L, Lindner S, Vettermann F, Brendel M, Wenter V, Ertl-Wagner B, Herms J, Wetzel C, Rupprecht R, Tonn JC, Belka C, Bartenstein P, Niyazi M, Albert NL.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):580-590. doi: 10.1007/s00259-018-4166-1. Epub 2018 Sep 22.

PMID:
30244386
44.

Role of amino-tracer PET for decision-making in neuro-oncology.

Suchorska B, Albert NL, Tonn JC.

Curr Opin Neurol. 2018 Dec;31(6):720-726. doi: 10.1097/WCO.0000000000000616. Review.

PMID:
30239359
45.

Voxel-wise analysis of dynamic 18F-FET PET: a novel approach for non-invasive glioma characterisation.

Vomacka L, Unterrainer M, Holzgreve A, Mille E, Gosewisch A, Brosch J, Ziegler S, Suchorska B, Kreth FW, Tonn JC, Bartenstein P, Albert NL, Böning G.

EJNMMI Res. 2018 Sep 10;8(1):91. doi: 10.1186/s13550-018-0444-y.

46.

Neurosarcoidosis Mimics High-Grade Glioma in Dynamic 18F-FET PET Due to LAT Expression.

Unterrainer M, Diekmann C, Dorostkar M, Vettermann FJ, Kümpfel T, Tonn JC, Bartenstein P, Albert NL.

Clin Nucl Med. 2018 Nov;43(11):840-841. doi: 10.1097/RLU.0000000000002266.

PMID:
30179915
47.

Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.

Huang RY, Bi WL, Weller M, Kaley T, Blakeley J, Dunn I, Galanis E, Preusser M, McDermott M, Rogers L, Raizer J, Schiff D, Soffietti R, Tonn JC, Vogelbaum M, Weber D, Reardon DA, Wen PY.

Neuro Oncol. 2019 Jan 1;21(1):26-36. doi: 10.1093/neuonc/noy137.

48.

DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.

Witt H, Gramatzki D, Hentschel B, Pajtler KW, Felsberg J, Schackert G, Löffler M, Capper D, Sahm F, Sill M, von Deimling A, Kool M, Herrlinger U, Westphal M, Pietsch T, Reifenberger G, Pfister SM, Tonn JC, Weller M; German Glioma Network.

Neuro Oncol. 2018 Nov 12;20(12):1616-1624. doi: 10.1093/neuonc/noy118.

49.

Low-Dose versus Therapeutic Range Intravenous Unfractionated Heparin Prophylaxis in the Treatment of Patients with Severe Aneurysmal Subarachnoid Hemorrhage After Aneurysm Occlusion.

Kunz M, Siller S, Nell C, Schniepp R, Dorn F, Huge V, Tonn JC, Pfister HW, Schichor C.

World Neurosurg. 2018 Sep;117:e705-e711. doi: 10.1016/j.wneu.2018.06.118. Epub 2018 Jun 27.

PMID:
29959066
50.

18F-FET-PET as a biomarker for therapy response in non-contrast enhancing glioma following chemotherapy.

Suchorska B, Unterrainer M, Biczok A, Sosnova M, Forbrig R, Bartenstein P, Tonn JC, Albert NL, Kreth FW.

J Neurooncol. 2018 Sep;139(3):721-730. doi: 10.1007/s11060-018-2919-0. Epub 2018 Jun 8.

PMID:
29948765

Supplemental Content

Support Center